The report focuses on the Contract Research Organization (CRO) and CDMO for Pharmaceutical market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Contract Research Organization (CRO) and CDMO for Pharmaceutical market.
Major Players in the Contract Research Organization (CRO) and CDMO for Pharmaceutical market are:
Pharmaceutical Product Development Inc
IQVIA HOLDINGS INC
Patheon
SGS SA
Siegfried
Recipharm
ICON PLC
Piramal
PRA HEALTH SCIENCES, INC
Syneos Health Inc
EPS INTERNATIONAL
Aenova
Laboratory Corporation of America Holdings (LABCORP)
WuXi PharmaTech
Envigo
GenScript Biotech Corporation
EVOTEC AG
PAREXEL International Corporation
Amatsigroup
Strides Shasun
Charles River Laboratories, Inc
Medpace Holdings, Inc
Catalent
Eurofins Scientific
AMRI3
On the basis of types, the Contract Research Organization (CRO) and CDMO for Pharmaceutical market is primarily split into:
Development
API production
Formulation
On the basis of applications, the market covers:
Pharmaceutical
Biopharmaceutical
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Overview
1.1 Product Overview and Scope of Contract Research Organization (CRO) and CDMO for Pharmaceutical
1.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Segmentation by Type
1.2.1 Global Production Market Share of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Segmentation by Application
1.3.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Contract Research Organization (CRO) and CDMO for Pharmaceutical (2014-2029)
Chapter 2 Global Economic Impact on Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Competition by Manufacturers
3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production and Share by Manufacturers (2020 and 2022)
3.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers Contract Research Organization (CRO) and CDMO for Pharmaceutical Manufacturing Base Distribution, Production Area and Product Type
3.5 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Competitive Situation and Trends
3.5.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Concentration Rate
3.5.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue (Value) by Region (2014-2022)
4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production by Region (2014-2022)
4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Market Share by Region (2014-2022)
4.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue, Price and Gross Margin (2014-2022)
Chapter 5 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption by Regions (2014-2022)
5.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Consumption, Export, Import by Regions (2014-2022)
Chapter 6 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue (Value), Price Trend by Type
6.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production and Market Share by Type (2014-2022)
6.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Market Share by Type (2014-2022)
6.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Price by Type (2014-2022)
6.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Growth by Type (2014-2022)
Chapter 7 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Application
7.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption and Market Share by Application (2014-2022)
7.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Contract Research Organization (CRO) and CDMO for Pharmaceutical Manufacturing Cost Analysis
8.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Contract Research Organization (CRO) and CDMO for Pharmaceutical
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast (2022-2029)
12.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Revenue Forecast (2022-2029)
12.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production Forecast by Type (2022-2029)
12.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Forecast by Application (2022-2029)
12.5 Contract Research Organization (CRO) and CDMO for Pharmaceutical Price Forecast (2022-2029)
Chapter 13 Appendix